MEDIFAST (MED)
(Delayed Data from NYSE)
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 5:20 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 5:20 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Campbell Soup (CPB) Looks Troubled: Cost Inflation a Major Hurdle
by Zacks Equity Research
Campbell Soup (CPB) is battling margin concerns due to elevated inflation, a rise in supply-chain expenses and some executional headwinds related to the transformation plan. Management recently cut the EPS view.
Sysco's (SYY) Recipe for Growth Solid, International Sales Soft
by Zacks Equity Research
Sysco Corporation (SYY) is well placed, thanks to its Recipe for Growth and business transformation efforts. However, International unit sales have been soft due to lockdowns in certain regions.
Kimberly-Clark's (KMB) K-C Professional Unit Soft, Costs High
by Zacks Equity Research
Kimberly-Clark's (KMB) K-C Professional unit sales are declining year over year due to hurdles related to coronavirus. The company is also seeing escalated costs.
Conagra (CAG) Benefits From Pandemic-Led Demand, Acquisitions
by Zacks Equity Research
Conagra's (CAG) retail business is benefiting from pandemic-led at-home consumption trend. Also, the company is strongly committed toward undertaking innovation.
Church & Dwight (CHD) Gains on Elevated Demand, High Costs Hurt
by Zacks Equity Research
Church & Dwight (CHD) is benefiting from increased consumer demand amid the pandemic-led higher at-home consumption. However, the company expects input costs to increase in 2021.
Service Corporation (SCI) Looks Solid, Gains About 10% in 3 Months
by Zacks Equity Research
Service Corporation (SCI) is gaining on increased funeral services performed and greater burials in its cemeteries, especially amid the pandemic. Also, a robust cost structure is aiding.
Tyson Foods (TSN) Rallies More than 20% YTD: Will Momentum Stay?
by Zacks Equity Research
Tyson Foods (TSN) is seeing robust growth in the retail business amid pandemic-induced at-home consumption trend. Also, its e-commerce business is impressive.
Buyouts Aids Flowers Foods (FLO), Soft Branded Retail Unit Hurts
by Zacks Equity Research
Flowers Foods (FLO) is focusing on buyouts to expand in untapped markets. However, softness in branded retail and store branded retail categories are a concern.
Philip Morris (PM) Rewards Shareholders, Unveils New Buyback Plan
by Zacks Equity Research
Philip Morris (PM) approves a new share buyback plan of up to $7 billion and announces a quarterly dividend. Solid pricing power and strength in RRPs are key growth drivers for the company.
Kraft Heinz (KHC) to Buy Assan Foods, Expand Presence in Turkey
by Zacks Equity Research
Kraft Heinz (KHC) will buy sauces-focused business, Assan Foods, to accelerate international growth strategy based on Taste Elevation and foodservice platform.
Pandemic-Led Demand Aids B&G Foods (BGS), Higher Costs Hurt
by Zacks Equity Research
B&G Foods' (BGS) retail business is benefiting from high pandemic-led at home consumption. However, rising expenses associated with COVID-19 as well as cost inflation are a concern.
The Zacks Rank Explained: How to Find Strong Buy Consumer Staples Stocks
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Hormel Foods' (HRL) Capacity Expansion Efforts Solid, Costs High
by Zacks Equity Research
Hormel Foods (HRL) has been gaining on its efforts to boost capacity and its prudent buyouts. However, high input and freight costs pose concerns.
Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining on constant product launches and strategic partnerships. The company's 2021 guidance looks encouraging.
United Natural (UNFI) Stock Tumbles Despite Q3 Earnings Beat
by Zacks Equity Research
United Natural's (UNFI) third-quarter fiscal 2021 results reflect lower top and bottom line due to weakness across almost all channels.
Campbell (CPB) Q3 Earnings & Sales Lag Estimates, EPS View Cut
by Vrishali Bagree
Campbell Soup's (CPB) third-quarter fiscal 2021 results reflect soft earnings and sales. Comparisons with year-ago period's demand surge and rising cost inflation hurt the company.
Philip Morris (PM) Firm on 2021 View, Duty-Free Unit Weak
by Zacks Equity Research
Philip Morris (PM) continues to expect adjusted earnings in the range of $5.95-$6.05 for 2021. The company does not expect any near-term recovery in the duty-free business.
Flowers Foods (FLO) Buys Koffee Kup Bakery's Assets to Aid Growth
by Zacks Equity Research
Flowers Foods (FLO) acquires assets of Koffee Kup Bakery, Inc. to expand presence in the key Northeast market.
Hormel Foods' (HRL) Planters Snacking Business Buyout to Aid Growth
by Zacks Equity Research
Hormel Foods (HRL) acquires Planters snacking portfolio from The Kraft Heinz Company. The buyout will enhance the snacking portfolio.
Clorox (CLX) Expands Portfolio With Hamilton Beach Deal
by Zacks Equity Research
Clorox (CLX) to expand its surface and air disinfecting products through its latest multi-year licensing deal with Hamilton Beach Brands. Also, this is in line with the company's IGNITE plan.
SpartanNash's (SPTN) Q1 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts mixed results for the first quarter of 2021. The company's segmental sales decline weighs on the overall top line.
What Makes Medifast (MED) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Medifast (MED) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Is Medifast (MED) Up 27.6% Since Last Earnings Report?
by Zacks Equity Research
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The J.M. Smucker (SJM) Q4 Earnings Top Estimates, Sales Down
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter fiscal 2021 results reflect lower sales and earnings thanks to weakness across most segments. Nevertheless, sustained demand for at-home food was an upside.
Medifast (MED) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Medifast (MED) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.